Risperdal is approved for irritability associated with autistic disorder in children and adolescents. The FDA label sets the starting dose at 0.5 mg once daily for patients weighing less than 20 kg and 0.5 mg twice daily for those weighing 20 kg or more. Clinicians typically titrate upward every few days in increments of 0.5 mg or less, guided by clinical response and tolerability.
How do weight-based dosing rules differ between children and adults?
Pediatric dosing starts lower and adjusts more slowly than adult regimens. Adults with bipolar mania or schizophrenia begin at 2 mg or 2 mg twice daily, respectively, while autistic irritability dosing remains weight-based regardless of age. No separate adult starting dose exists for this specific indication.
When do clinicians increase the dose after initiation?
Most protocols raise the dose on day 4 and again on day 7, or sooner if symptoms persist and side effects are minimal. Increases are capped at 0.5 mg increments to limit sedation, weight gain, and extrapyramidal symptoms.
What side effects prompt parents to call the prescriber early?
Parents most often report daytime drowsiness, increased appetite, nasal congestion, or tremor. Less common but urgent concerns include muscle stiffness, fever, or rapid heartbeat, which can signal rare but serious reactions such as neuroleptic malignant syndrome.
How long does it usually take to reach a stable maintenance dose?
Titration to the lowest effective dose typically occurs within two to three weeks. Once behavior stabilizes, prescribers often reassess monthly and may attempt a slow taper if irritability remains controlled for several months.
Can lower doses be effective in very young children?
Some clinicians start at 0.25 mg daily for toddlers under 15 kg and still observe meaningful reductions in irritability. Controlled trials show benefit at total daily doses as low as 0.5 mg, supporting individualized, conservative dosing.
What monitoring schedule is recommended during the first month?
Baseline height, weight, fasting glucose, and lipid panel are obtained before starting. Follow-up visits occur at one and two weeks, then monthly, to track metabolic changes, prolactin levels, and movement abnormalities.
When does the risperidone patent expire and will generics remain available?
The key U.S. patents for Risperdal expired years ago; generic risperidone tablets and oral solution are widely marketed. No new exclusivity periods block continued generic availability.
How does risperidone compare with aripiprazole for this use?
Both agents carry FDA approval for autistic irritability. Risperidone tends to show slightly faster onset of behavioral control, while aripiprazole may produce less weight gain and prolactin elevation. Choice often hinges on side-effect profiles and insurance coverage.